SWTX

SpringWorks Therapeutics, Inc.

36.83 USD
-0.89 (-2.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

SpringWorks Therapeutics, Inc. stock is up 1.97% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 July’s closed higher than June. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
28 May 19:28 19 Jul, 2024 35.00 CALL 35 0
28 May 19:33 19 Jul, 2024 35.00 CALL 54 0
28 May 19:36 19 Jul, 2024 35.00 CALL 74 0
20 Jun 17:34 19 Jul, 2024 40.00 CALL 200 7

About SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors.